4//SEC Filing
Zung Jonathan B. 4
Accession 0001694665-21-000019
CIK 0001694665other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 5:28 PM ET
Size
5.4 KB
Accession
0001694665-21-000019
Insider Transaction Report
Form 4
Zung Jonathan B.
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-27+300,000→ 300,000 totalExercise: $16.65Exp: 2031-01-27→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]This option will vest as to 25% of the total grant on January 4, 2022 and the remainder vesting thereafter in thirty-six (36) substantially equal monthly installments, subject to continued employment on such dates.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001837972
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 5:28 PM ET
- Size
- 5.4 KB